Sign in
4

Changes in Ownership

Foghorn Therapeutics Inc. Filed Acc 0001562180-24-005358

Options or other derivatives

  • Director acquired 16,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cole Douglas G. Director 2024-06-26 Grant or award · Stock Options (Right to buy) +16,000 $5.52 $88,320 16,000 D
Loading xslF345X05/primarydocument.xml…